Article
Adenovirus-mediated interleukin-2 production by tumors induces growth of cytotoxic tumor-infiltrating lymphocytes against human renal cell carcinoma.
Journal of immunotherapy (Hagerstown, Md. : 1997) - 1 May 1998
Mulders P, Tso C L, Pang S, Kaboo R, McBride W H, Hinkel A, Gitlitz B, Dannull J, Figlin R, Belldegrun A
Abstract excerpt
Combination therapy with interleukin-2 (IL-2) and tumor-infiltrating lymphocytes (TILs) demonstrates significant clinical activity in patients with metastatic renal cell carcinoma (RCC). To investigate whether local delivery of IL-2 via gene transfer is capable of improving the potency and efficacy of in vitro propagated TILs as compared with standard growth conditions [400 BRMP U (BU)/ml], a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
